BiotechTube

Choline Chloride for Injection + Placebo

Phase 2/3Recruiting
0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Choline Deficiency

Conditions

Choline Deficiency, Liver Injury

Trial Timeline

Dec 10, 2025 → Jun 1, 2028

NCT ID
NCT06910943

About Choline Chloride for Injection + Placebo

Choline Chloride for Injection + Placebo is a phase 2/3 stage product being developed by Protara Therapeutics for Choline Deficiency. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06910943. Target conditions include Choline Deficiency, Liver Injury.

Hype Score Breakdown

Clinical
15
Activity
15
Company
5
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT06910943Phase 2/3Recruiting

Competing Products

2 competing products in Choline Deficiency

See all competitors
ProductCompanyStageHype Score
AZD8848AstraZenecaPhase 1
29
Dupilumab + PlaceboSanofiPhase 2
35